Medication info
SBIA Tablets 100 mg (Sitagliptin Hydrochloride Monhydrate)

SBIA Tablets 100 mg (Sitagliptin Hydrochloride Monhydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Pale orange, round, biconvex film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202005818 · Approved 2020.08.14 · Insurance code 670502280

Summary

Main use
Improvement of blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used together with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, and if blood sugar control is difficult with monotherapy and the patient has no prior experience with diabetes medication, it may be used in combination with metformin. Additionally, when blood sugar control is insufficient with sulfonylureas, metformin, thiazolidinediones, or insulin monotherapies, this medication can be added to strengthen blood sugar management. If adequate blood sugar control is not achieved with the combination of two or more medications, this medication can be added for effective blood sugar improvement. Therefore, this medication is flexibly utilized in various treatment situations to improve blood sugar control in patients.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions; therefore, if symptoms such as skin swelling or difficulty breathing occur, the medication should be discontinued immediately and a healthcare professional should be consulted. This medication may cause a serious pancreatic disease known as pancreatitis, so if symptoms such as abdominal pain, vomiting, or nausea occur during use, it is important to inform medical personnel promptly. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be administered if there is a severe allergy to this medication or its components. Patients with impaired kidney function may require dosage adjustments for this medication, so kidney function tests should be conducted before use, and the physician's instructions should be followed. While taking this medication, side effects similar to cold symptoms, headaches, diarrhea, and nausea may occur, particularly attention should be paid to hypoglycemia symptoms. When taken with other antidiabetic medications or insulin, the risk of hypoglycemia may increase, and the physician may adjust the medication dosage as necessary. If severe joint pain or skin blisters occur, notify a doctor immediately and discontinue medication use. Pregnant or breastfeeding women should preferably avoid this medication, and safety and effectiveness have not been established in children under 18 years of age. Elderly patients may have a possibility of decreased kidney function, so regular monitoring of kidney function should be conducted, and dosage adjustments may be needed as necessary. In cases of overdose, measures such as gastrointestinal decontamination or clinical monitoring including electrocardiogram tests will be implemented, and some may be removed by hemodialysis if necessary.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
Show 26 more
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • arthralgia with severity and disability
  • bullous pemphigoid-like dermatitis
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • increased low-density lipoprotein
  • hyperglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is advisable to maintain storage temperature between 1°C and 30°C at room temperature. By storing it this way, the efficacy of the medication can be safely maintained.

Appearance and packaging

Appearance

Pale orange, round, biconvex film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.